Prosecution Insights
Last updated: August 17, 2026

Examiner: LEVIN, JOEL D

Tech Center 1600 • Art Units: 1600 1633

This examiner grants 56% of resolved cases

Performance Statistics

56.4%
Allow Rate
-3.6% vs TC avg
99
Total Applications
+46.5%
Interview Lift
1529
Avg Prosecution Days
Based on 78 resolved cases, 2023–2026

Rejection Statute Breakdown

4.1%
§101 Eligibility
14.7%
§102 Novelty
49.6%
§103 Obviousness
25.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17605207 COMPOSITIONS AND METHODS CHARACTERIZING METASTASIS Final Rejection Dana-Farber Cancer Institute, Inc.
17615382 ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF CYSTATHIONINE BETA-SYNTHASE (CBS) ENZYME FOR TREATING CBS DEFICIENCY Non-Final OA Cornell University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month